Optimal Sensor Association and Data Collection in Power Materials Warehouse Based on Internet of Things von He, Fangqiuzi, Xu, Junfeng, Zhong, Jinglin, Chen, Guang, Peng, Shixin

Volltext

Safety profile of baricitinib for the treatment of rheumatoid arthritis over a median of 3 years of treatment: an updated integrated safety analysis von Genovese, Mark C, Smolen, Josef S, Takeuchi, Tsutomu, Burmester, Gerd, Brinker, Dennis, Rooney, Terence P, Zhong, Jinglin, Daojun, Mo, Saifan, Chadi, Cardoso, Anabela, Issa, Maher, Wu, Wen-Shuo, Winthrop, Kevin L

Volltext

Rural Post-Earthquake Resettlement Mode Choices: Empirical Case Studies of Sichuan, China von Zhao, Lei, Zhou, Sifan, Zhong, Jinglin, Ao, Yibin, Wang, Yan, Wang, Tong, Chen, Yunfeng

Volltext

Determinants of villagers’ satisfaction with post-disaster reconstruction: Evidence from surveys ten years after the Wenchuan earthquake von Ao, Yibin, Zhong, Jinglin, Zhang, Zijun, Han, Lili, Wang, Yan, Chen, Yunfeng, Wang, Tong

Volltext

Households’ Earthquake Disaster Preparedness Behavior: The Role of Trust in and Help From Stakeholders von Ao, Yibin, Tan, Liyao, Tan, Ling, Zhong, Jinglin, Zhang, Hongying, Wang, Yan, Wang, Tong

Volltext

3D Simulation of Large Hull Shell Surface based on 3D Digital Video von Zhong, Jinglin

Volltext

Factors Driving BIM Learning Performance: Research on China’s Sixth National BIM Graduation Design Innovation Competition of Colleges and Universities von Ao, Yibin, Liu, Yunhong, Tan, Liyao, Tan, Ling, Zhang, Maoqiu, Feng, Qiqi, Zhong, Jinglin, Wang, Yan, Zhao, Liang, Martek, Igor

Volltext

Application of hypothetical strategies in acute pain von Zhong, Jinglin, Petullo, David

Volltext

Identification of renal cyst cells of type I Nephronophthisis by single-nucleus RNA sequencing von Wang, Qianying, Zou, Baojuan, Wei, Xiaoya, Lin, Hongrong, Pang, Changmiao, Wang, Lei, Zhong, Jinglin, Chen, Huamu, Gao, Xuefei, Li, Min, Ong, Albert C. M., Yue, Zhihui, Sun, Liangzhong

Volltext

219 Safety summary results of baricitinib focusing on serious infections events and preselected comorbidities von Combe, Bernard, Balsa, Alejandro, Winthrop, Kevin, Tony, Hans-Peter, Genovese, Mark C, Harigai, Masayoshi, Smolen, Josef S, Emery, Paul, Dudler, Jean, Hall, Stephen, Zerbini, Cristiano A, Van Den Bosch, Filip, Durand, Frederick, Arthanari, Subhashini, Rogai, Veronica, Zhong, Jinglin, Meszaros, Gabriella, Dougados, Maxime

Volltext

Safety and Efficacy of Baricitinib in Patients Receiving Conventional Synthetic Disease-Modifying Antirheumatic Drugs or Corticosteroids von van Vollenhoven, Ronald, Helt, Cameron, Arora, Vipin, Zhong, Jinglin, Correia, Ana Pinto, de la Torre, Inma, Muram, David

Volltext

Statistical Issues of QT Prolongation Assessment Based on Linear Concentration Modeling von Tsong, Yi, Shen, Meiyu, Zhong, Jinglin, Zhang, Joanne

Volltext

Design and fabrication of a single metal layer tunable metamaterial absorber in THz range von Zhong, Min, Jiang, Xiaoting, Zhu, Xuliang, Zhang, Jing, Zhong, Jinglin

Volltext

Baricitinib in patients with moderate-to-severe atopic dermatitis: Results from a randomized monotherapy phase 3 trial in the United States and Canada (BREEZE-AD5) von Simpson, Eric L., Forman, Seth, Silverberg, Jonathan I., Zirwas, Matthew, Maverakis, Emanual, Han, George, Guttman-Yassky, Emma, Marnell, Daniel, Bissonnette, Robert, Waibel, Jill, Nunes, Fabio P., DeLozier, Amy M., Angle, Robinette, Gamalo, Margaret, Holzwarth, Katrin, Goldblum, Orin, Zhong, Jinglin, Janes, Jonathan, Papp, Kim

Volltext

Design and preparation of a single-band tunable metamaterial absorber in terahertz frequency von Zhong, Min, Jiang, Xiaoting, Zhu, Xuliang, Zhang, Jing, Zhong, Jinglin

Volltext

50351 Lebrikizumab maintains clinically meaningful outcomes with treatment administered every 4 weeks in adult and adolescent patients with moderate-to-severe atopic dermatitis von Gold, Linda Stein, Schuttelaar, Marie Louise, Prajapati, Vimal H., Homey, Bernhard, Strowd, Lindsay, Dossenbach, Martin, Liu, Chunyuan, Zhong, Jinglin, Pierce, Evangeline, Agell, Helena, Silvestre, Juan Francisco

Volltext

Validation Testing in Thorough QT/QTc Clinical Trials von Tsong, Yi, Zhong, Jinglin, Chen, Wen Jen

Volltext

42136 Lebrikizumab improvement in itch reduction at 52 weeks in patients with moderate-to-severe atopic dermatitis: pooled analysis of two phase 3 randomized controlled trials von Yosipovitch, Gil, Lio, Peter, Rosmarin, David, Legat, Franz, Carrascosa, Jose Manuel, Meskimen, Eric, Casillas, Marta, Pierce, Evangeline, Liu, Zhuqing, Zhong, Jinglin, Ständer, Sonja

Volltext

41916 Lebrikizumab reduced interference of itch on sleep at 52 weeks in patients with moderate-to- severe atopic dermatitis: pooled analysis of two phase 3 randomized controlled tr... von Yosipovitch, Gil, Lio, Peter A., Rosmarin, David, Legat, Franz J., Carrascosa, Jose-Manuel, Meskimen, Eric, Casillas, Marta, Pierce, Evangeline, Xu, Chenjia, Zhong, Jinglin

Volltext

Efficacy of Lebrikizumab in Patients With Atopic Dermatitis and Atopic Comorbidities: Pooled Results From Two Phase 3 Monotherapy Randomized, Double-Blind, Placebo-Controlled 16-We... von Sher, Ellen, Boguniewicz, Mark, Golant, Alexandra, Zhong, Jinglin, Atwater, Amber Reck, Dawson, Zach, Siu, Kimberly, de Bruin-Weller, Marjolein, Carrascosa, Jose-Manuel, Thyssen, Jacob

Volltext